¶ Merck
.png)
This page has moved! Click here to view the most up-to-date version of this page on the White Rose Wiki.
Merck & Co., Inc. is an American multinational pharmaceutical company based in Kenilworth, New Jersey.[1]
¶ History
In May 2002, The Bill & Melinda Gates Foundation purchased stock in Merck.[2]
On August 5, 2010, Merck and the Gates Foundation announced a joint five-year $60 million contribution to the African Comprehensive HIV/AIDS Partnerships for efforts related to HIV/AIDS and tuberculosis in Botswana.[3]
¶ COVID-19
Near the end of March 2020, Merck joined the COVID-19 Therapeutics Accelerator alongside a "consortium of life sciences companies."[4]
Merck collaborated with Ridgeback Biotherapeutics to develop molnupiravir, an oral mutagenic anti-viral compound, to treat COVID-19. In October 2021, the two companies reported that data from their Phase 3 clinical trial showed molnupiravir “cuts the risk of hospitalization and death from COVID-19 by 50% in people who have mild to moderate forms of the disease.”[5][6]
On November 30, 2021, the Food and Drug Administration (FDA)'s Antimicrobial Drugs Advisory Committee narrowly recommended the use of molnupiravir in a 13-10 vote.[7]
On December 3, 2021, Merck announced it had entered an agreement with the Government of Canada to supply the country with up to one million "patient courses" of molnupiravir.[8]
In January 2022, Merck and Ridgeback announced they would supply UNICEF with 3 million doses of molnupiravir through the Access to COVID-19 Tools Accelerator (ACT-Accelerator) Therapeutics Partnership.[9]
¶ Organization
¶ Funding
Merck has provided notable funding to:
¶ Partners
Merck is a partnered with or a member of:
- AcademyHealth[11]
- Acceleration Consortium
- Medical CBRN Defense Consortium (MCDC)[12]
- World Economic Forum[13]
¶ Subsidiaries
¶ External links
The Trusted Provider of Medical Information since 1899. Merck Manuals. Retrieved January 18, 2022, from https://archive.ph/nYPYj ↩︎
Bank, D., & Buckman, R. (2002, May 17). Gates Foundation buys stakes in drug makers. Wall Street Journal. https://archive.ph/XP9QA ↩︎
Merck, Gates Foundation Give $60 Million to Fight HIV/AIDS in Botswana. (2010, August 25). Philanthropy News Digest; Candid. http://archive.today/2023.06.21-180752/https://philanthropynewsdigest.org/news/merck-gates-foundation-give-60-million-to-fight-hiv-aids-in-botswana ↩︎
Staines, R. (2020, March 26). Pharma giants including Novartis collaborate on COVID-19 therapies. Pharmaphorum. http://archive.today/2022.01.18-165943/https://pharmaphorum.com/news/collaborate-covid19-therapies/ ↩︎
Moody, M., Ryan, P., Dannenbaum, P., Kruper, R., & Carvalho, C. (2021, October 1). Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study. Merck. Retrieved December 5, 2021, from https://archive.ph/Ov4Cg ↩︎
Halford, B., Howes, L., & Satyanarayana, M. (2021, October 1). Molnupiravir reduces risk of hospitalization and death in patients with mild to moderate COVID-19. Chemical & Engineering News; American Chemical Society. https://archive.ph/8sJfE ↩︎
Lee, J. (2021, November 30). FDA advisers recommend Merck’s COVID-19 pill in close vote. MarketWatch. https://ghostarchive.org/archive/X40X1 ↩︎
Kilgore, T. (2021, December 3). Merck to supply Government of Canada with up to 1 million courses molnupiravir, its COVID-19 pill. MarketWatch. Retrieved December 5, 2021, from http://archive.today/2021.12.06-015701/https://www.marketwatch.com/story/merck-to-supply-government-of-canada-with-up-to-1-million-courses-molnupiravir-its-covid-19-pill-2021-12-03 ↩︎
Moody, M. (2022, January 18). Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine. Merck. https://archive.ph/gpZRy ↩︎
Who we are. (2021, May 12). 19 to Zero. https://web.archive.org/web/20210512021256/https://www.19tozero.ca/who-we-are ↩︎
Current Organizational Members. AcademyHealth. Retrieved May 8, 2022, from https://archive.ph/CjV83 ↩︎
Current Members. MCDC. Retrieved January 3, 2023, from http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/ ↩︎
Merck. World Economic Forum. Retrieved February 10, 2022, from https://archive.ph/a7J76 ↩︎